52 Upper St
London
N1 0QH
UK
By: Wendy Lewis, Founder & President, Wendy Lewis & Co Ltd.
The iconic Angel area of London was a fitting location for FACE 2025 which attracted visitors from all over Europe, Asia and the USA. With over 20 years of congresses, FACE is well known for having a robust programme with an international faculty, that includes in-depth topics and timely innovations across medical aesthetics, dermatology and cosmetic surgery. Each year the FACE Board introduces new developments with an eye to introduce up-to-the minute therapies and strategies for the business side for attendees.
Uliana Gout, who practises in London, is one of the FACE Scientific Directors. She noted that, ‘regenerative aesthetic medicine’ was the headline concept for Face 2025, saying: “We wanted to spearhead this important topic in the UK as the first conference to address this important global trend.” She added “Key take home messages included the importance of pioneering evidence alongside innovations in this space, to ensure we are leading with efficacy and safety. We explored hot topics of ‘functional aesthetics’, the future of fillers, global digitalisation, the ‘Ozempic face’ phenomenon as well as innovations in off-label treatments.”
Dermatologist Todd Schlessinger, from Charleston, South Carolina, is another FACE Scientific Director. He commented: “FACE London 2025, the UK’s premier scientific aesthetic medicine conference, was a resounding success! The outstanding faculty presented a wide variety of well-attended sessions with a great deal of interaction with meeting goers. New this year was a session covering inflammatory conditions and dermato-oncology, and Skin Care Masterclass sessions led by the founders of The Science of Skin Summit.”
The FACE team incorporated some new high-level topics that proved very popular with attendees. These included the impact of Glp-1 drugs, a robust session on regenerative medicine, hormonal heath talks, panels focused on artificial intelligence and social media for practices, sessions on new injectables, and developments in skincare.
Ali Pirayesh, Plastic & Reconstructive Surgeon from Amsterdam, and Associate Professor of Aesthetics and Reconstructive Surgery at UCL, said: “As biostimulators gain momentum over hyaluronic acid in clinical practice, we must also recognise the growing gap between popularity and evidence – especially with emerging trends like exosomes and salmon DNA, where high-quality research remains scarce. The UK aesthetic market, with its heterogeneous mix of practitioners, presents an exciting opportunity and complex challenges to curate educational content that is evidence-based, balanced, and inclusive.”
